Is Personalized Dietary Therapy Effective for Individuals With Irritable Bowel Syndrome?

被引:1
|
作者
Zarini, Gustavo G. [1 ]
McLean, Michael A. [1 ]
Delgado, Savina I. [1 ]
机构
[1] Oxford Biomed Technol Inc, 3555 Fiscal Ct,Suite 9, Riviera Beach, FL 33404 USA
关键词
Personalized diet; irritable bowel syndrome; lifestyle eating and performance program; leukocyte activation assay; quality of life; QUALITY-OF-LIFE; FOOD INTOLERANCE; GASTROINTESTINAL SYMPTOMS; MANAGEMENT; IBS; HYPERSENSITIVITY; PREVALENCE; IMPACT; COMMON;
D O I
10.1177/15598276221112309
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Adverse reactions to foods and food additives have a critical role in clinical manifestations of irritable bowel syndrome (IBS). Personalized dietary modifications conducted under the supervision of a qualified health practitioner could considerably impact the clinical care and course of the condition. Objective: To investigate the clinical effectiveness of the Lifestyle Eating and Performance (LEAP) program based on the Leukocyte Activation Assay-MRT (LAA-MRT (R)) results in improving IBS symptoms and quality of life. Methods: The retrospective study included de-identified client records (n = 146) from private group practices seen by registered dietitians. The eligibility criteria were adults aged > 18 years old with an established diagnosis of IBS. Results: Participants were 46.7 +/- 12.6 years old and had a BMI of 26.7 +/- 6.1 kg/m(2); the majority were female (87.0%) and followed-up by a registered dietitian for 10.1 +/- 6.4 weeks. There was a significant reduction post-dietary intervention in overall Global Gastrointestinal Symptom Survey Scores (P < 0.001) and improvement in quality of life (P < 0.001). Conclusion: This study generates real-world evidence of an alternative treatment option for IBS using a personalized dietary approach. A more precise understanding of the effect of food intake reactions is vital for clinical improvements and enhancing health outcomes in IBS.
引用
收藏
页码:317 / 325
页数:9
相关论文
共 50 条
  • [31] Rifaximin Therapy of Irritable Bowel Syndrome
    Koo, Hoonmo L.
    Sabounchi, Saman
    Huang, David B.
    DuPont, Herbert L.
    CLINICAL MEDICINE INSIGHTS-GASTROENTEROLOGY, 2012, 5 : 31 - 41
  • [32] Irritable bowel syndrome - diagnostics and therapy
    Pohl, D.
    Heinrich, H.
    Misselwitz, B.
    GASTROENTEROLOGE, 2013, 8 (05): : 417 - 424
  • [33] Drug therapy for irritable bowel syndrome
    Moennikes, H.
    Schmidtmann, M.
    van der Voort, I. R.
    INTERNIST, 2006, 47 (10): : 1073 - +
  • [34] Yoga as a Therapy for Irritable Bowel Syndrome
    Adrijana D’Silva
    Glenda MacQueen
    Yasmin Nasser
    Lorian M. Taylor
    Jeff K. Vallance
    Maitreyi Raman
    Digestive Diseases and Sciences, 2020, 65 : 2503 - 2514
  • [35] Probiotic therapy of the irritable bowel syndrome
    Enck, P.
    Klosterhalfen, S.
    Martens, U.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (08) : 371 - 375
  • [36] Therapy options in irritable bowel syndrome
    Enck, Paul
    Junne, Florian
    Klosterhalfen, Sibylle
    Zipfel, Stephan
    Martens, Ute
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (12) : 1402 - 1411
  • [37] Irritable bowel syndrome diagnostics and therapy
    Pohl, D.
    Heinrich, H.
    Misselwitz, B.
    COLOPROCTOLOGY, 2014, 36 (03) : 190 - 195
  • [38] Pharmacologic therapy for the irritable bowel syndrome
    Talley, NJ
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (04): : 750 - 758
  • [39] Are probiotics effective in management of irritable bowel syndrome?
    Hosseini, Asieh
    Nikfar, Shekoufeh
    Abdollahi, Mohammad
    ARCHIVES OF MEDICAL SCIENCE, 2012, 8 (03) : 403 - 405
  • [40] Effectiveness of Two Dietary Approaches on the Quality of Life and Gastrointestinal Symptoms of Individuals with Irritable Bowel Syndrome
    Guerreiro, Maria Margarida
    Santos, Zelia
    Carolino, Elisabete
    Correa, Julieta
    Cravo, Marilia
    Augusto, Fatima
    Chagas, Cristina
    Guerreiro, Catarina Sousa
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)